Skip to main content

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Volume 9, Number 2, April 2010

Articles

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Impact of the CD40-CD40L Dyad in Alzheimer's Disease
pp. 149-155(7)
Authors: Giunta, Brian; Rezai-Zadeh, Kavon; Tan, Jun

Favourites:
ADD

Microglia and Inflammation in Alzheimer's Disease
pp. 156-167(12)
Authors: Mandrekar-Colucci, Shweta; Landreth, Gary E.

Favourites:
ADD

Mechanisms of Mononuclear Phagocyte Recruitment in Alzheimer's Disease
pp. 168-173(6)
Authors: Hickman, Suzanne E.; Khoury, Joseph El

Favourites:
ADD

Assessing Activation States in Microglia
pp. 174-191(18)
Authors: Colton, Carol A.; Wilcock, Donna M.

Favourites:
ADD

Amyloid-β Immunotherapy for Alzheimer's Disease
pp. 197-206(10)
Authors: Fu, H.J.; Liu, B.; Frost, J.L.; Lemere, C.A.

Favourites:
ADD
Favourites:
ADD

Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition
pp. 217-231(15)
Authors: Hoffner, G.; Andre, W.; Vanhoutteghem, A.; Soues, S.; Djian, P.

Favourites:
ADD

Novel Anti-Inflammatory and Neuroprotective Agents for Parkinson's Disease
pp. 232-240(9)
Authors: Lu, Li; Li, Fengqiao; Wang, Xiaomin

Favourites:
ADD

Treating Schizophrenia: Novel Targets for the Cholinergic System
pp. 241-256(16)
Authors: Money, T.T.; Scarr, E.; Udawela, M.; Gibbons, A.S.; Jeon, W.J.; Seo, M.S.; Dean, B.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more